Pascal Biosciences discovered cannabinoids activate the major histocompatibility complex to aid cancer treatment
On Sept. 23, 2019, Pascal Biosciences identified specific cannabinoids that enhance the immunogenicity of tumor cells, rendering them…
On Sept. 23, 2019, Pascal Biosciences identified specific cannabinoids that enhance the immunogenicity of tumor cells, rendering them…
On Sept. 12, 2019, UPenn completed its exclusive, 7-year research and development alliance with Novartis, that spawned the…
On Sept. 11, 2019, deCODE genetics in Iceland announced an agreement with a consortium of government, charity, researchers…
On Sept. 11, 2019, scientists at Sanford Burnham Prebys announced they had identified the long-sought structure of an…
On Sept. 9, 2019, IRBM announced the signing of a service and development agreement with The University of…
On Sept. 5, 2019, researchers at the Howard Hughes Medical Instituteï¾’s Janelia Research Campus announced that they had…
On Sept. 5, 2019, Penn Professor Virginia M.Y. Lee, PhD received the Breakthrough Prize in Life Sciences, in…
On Aug. 26, 2019, University of Alberta researcher Rick Rachubinski and colleagues announced they had discovered the protein…
On Aug. 26, 2019, Amgen acquired worldwide rights to Otezlaï¾® (apremilast), the only oral, non-biologic treatment for psoriasis…
On Aug. 26, 2019 , the City of Port St. Lucie Council voted 5 to 0 to ï¾ leaseï¾ …
On Aug. 23, 2019, the Centers for Disease Control and Prevention (CDC) released Immunization Practices Advisory Committee (ACIP)…
On Aug. 21, 2019, Georgia Institute of Technology researchers Chris Rozell and Garret Stanley received a $1.6 million…
On Aug. 21, 2019, the Siteman Cancer Center announced it was awarded a $15 million grant to better…
On Aug. 20, 2019, the eleventh U.S. CRISPR-Cas9 patent was awarded to University of California, the University of…
On Aug. 19, 2019, the Barbara Ann Karmanos Cancer Institute announced it became the first cancer center in…
On Aug. 16, 2019, the Centers for Disease Control and Prevention (CDC) published updated Immunization Practices Advisory Committee…
On Aug. 15, 2019, Masonic Cancer Center researchers Reuben Harris, PhD and Douglas Yee, MD announced that they…
On Aug. 15, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it was awarded…
On Aug. 1, 2019 the Siteman Cancer Center announced it was awarded a six-year, $7.8 million grant from…
On Jul. 29, 2019, Sylvester Comprehensive Cancer Center announced it had achieved National Cancer Institute (NCI) designation, becoming…
On Jul. 25, 2019, Vanderbilt University Medical Center Professor David Cortez, PhD and colleagues revealed a new DNA…
On Jul. 24, 2019, the Oregon Health Science University (OHSU) Transplant Program – one of the oldest, largest…
On Jul. 19, 2019, the Centers for Disease Control and Prevention (CDC) published recommendations from the Advisory Committee…
On Jul. 18, 2019, Chembio Diagnostics announced a collaboration with Shire Human Genetic Therapies, a wholly owned subsidiary…
On Jul. 9, 2019, the Masonic Cancer Center announced that researcher Ingunn Stromnes, PhD was awarded with a…
On Jul. 9, 2019, Vanderbilt Vaccine Center announced that Director James Crow Jr., MD, had been awarded half…
On Jul. 3, 2019, Evotec announced the strategic transaction to acquire Just Biotherapeutics, signed May 20, 2019, had…
In Jun. 2019, Defense Advanced Research Projects Agency (DARPA) announced it had funded a $21.9 gene modulation research…
On Jun. 27, 2019, Chembio Diagnostics announced that is had obtained a CE mark for its DPP Zika/Dengue/Chikungunya…
On Jun. 24, 2019, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (S.1379) passed by…